Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
19.2 EUR | +0.52% | +1.59% | +6.67% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 10.41 for the current year and 9.6 for next year, earnings multiples are highly attractive compared with competitors.
- The stock, which is currently worth 2024 to 0.39 times its sales, is clearly overvalued in comparison with peers.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
Ratings chart - Surperformance
Sector: Paper Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.67% | 218M | - | ||
+27.77% | 6B | B | ||
+32.70% | 2.7B | C- | ||
-4.75% | 1.61B | - | - | |
+7.19% | 1.52B | - | C | |
-17.32% | 1.19B | - | ||
+18.49% | 1.03B | - | ||
-17.90% | 872M | - | - | |
-13.53% | 820M | A- | ||
-5.22% | 778M | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- IBG Stock
- Ratings Iberpapel Gestión, S.A.